Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma

A. M. Pinto, C. Califano, F. Di Gennaro, A. De Renzo, L. Catalano, L. Pace

Research output: Contribution to journalArticlepeer-review

Abstract

Technetium-99m-Sestamibi (99mTc-sestamibi) scintigraphy has been shown to be capable of differentiating patients with multiple myeloma (MM) in remission from those with active disease. We studied 5 patients with MM (2 females and 3 males, age 53±17 years) before and after treatment. 99mTc-sestamibi scintigraphic results were concordant with clinical status.

Original languageEnglish
Pages (from-to)1000-1001
Number of pages2
JournalHaematologica
Volume85
Issue number9
Publication statusPublished - 2000

Keywords

  • 99m Tc-sestamibi
  • Multiple myeloma

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Technetium-99m sestamibi scintigraphy in monitoring patients with multiple myeloma'. Together they form a unique fingerprint.

Cite this